An In-Vitro Antimicrobial Study of Swarna Prashana
International Journal of Drug Delivery Technology · 25.04.2026 · 16 (19s)
DOI: 10.25258/ijddt.16.19s.68 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 25.04.2026. Verfasst von Khuleshwar Prasad und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Swarnaprashana is an ancient Ayurvedic formulation of Lehana, which has been mentioned in Kaumarbhritya for its immunoenhancing activity and the prevention of infectious diseases in children. Although this formulation has long been used, there is a lack of scientific evidence for its antimicrobial properties. The current study aims to assess the in vitro antibacterial activity of Swarnaprashana at varied doses against common newborn infections. The experimental study was conducted in vitro by the agar well diffusion method on Mueller-Hinton agar. Swarnaprashana was prepared by Swarna Bhasma, Madhu (honey), and Ghrita (clarified butter) in aseptic conditions. We tested the antibacterial activity against E. coli (MTCC 2592) and Staphylococcus aureus (MTCC 1430). Test samples included conventional Swarnaprashana in three concentrations (25%, 50%, and 100%) and Swarnaprashana in DMSO in corresponding concentrations. Antimicrobial activity was assessed by the measurement of zones of inhibition in millimetres. Normal Swarnaprashana presented dose-dependent antibacterial activity, with higher inhibition values for Staphylococcus aureus (15 mm at 50% and 23 mm at 100%) than for Escherichia coli (12 mm and 18 mm, respectively). Swarnaprashana, made with DMSO as a solvent, worked well against Staphylococcus aureus, with zones of inhibition of 14 mm at 25%, 18 mm at 50%, and 24 mm at 100% concentration. When DMSO is used as a solvent, it shows better antibacterial activity and diffusion properties. The inhibition zones were 18 mm at 25%, 21 mm at 50%, and 22 mm at 100% concentration against Escherichia coli. The present study establishes that Swarnaprashana has appreciable in vitro antibacterial activity, influenced by concentration, type of microbes, and solvent system. These results justify its traditional use and form a scientific basis for further in vivo and clinical studies.
Zitieren
APA
Prasad, K., Chandravanshi, L., Rathia, S., Misra, S., Thakur, P., Swarnkar, D., & Sahu, C. (2026). An In-Vitro Antimicrobial Study of Swarna Prashana. International Journal of Drug Delivery Technology, 16(19s). https://doi.org/10.25258/ijddt.16.19s.68
Vancouver
Prasad K, Chandravanshi L, Rathia S, Misra S, Thakur P, Swarnkar D, et al. An In-Vitro Antimicrobial Study of Swarna Prashana. International Journal of Drug Delivery Technology. 2026;16(19s). doi:10.25258/ijddt.16.19s.68
BibTeX
@article{Prasad2026,
author = {Prasad, Khuleshwar and Chandravanshi, Lowkesh and Rathia, Satyawati and Misra, Sibani and Thakur, Pragya and Swarnkar, Dikshit and Sahu, Chandani},
title = {An In-Vitro Antimicrobial Study of Swarna Prashana},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {19s},
doi = {10.25258/ijddt.16.19s.68}
}
EUVIMED